Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03583931 · ClinicalTrials.gov registry record · NA
Treatment of Complicated Parapneumonic Effusion With Fibrinolytic Therapy Versus VATs Decortication
A NA study, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03583931 is a NA study that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 10 participants.
The verdict
NCT03583931, a NA study, has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study aims to standardize the treatment of pleural space (parapneumonic) infections by comparing the difference in outcomes between 2 methods of treatment: early VATS (Video Assisted Thorascopic Surgery) decortication versus fibrinolytic therapy. During treatment, the patient's coagulopathy status will also be evaluated.
Interventions
- PROCEDURE VATS Decortication
- DRUG Fibrinolytic Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-07-26 |
| Est. Completion | 2020-02-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03583931
The ClinicalTrials.gov registry entry for NCT03583931 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Denver Health and Hospital Authority, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which VATS Decortication is the first listed.
NCT03583931 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03583931 about?
NCT03583931 is a clinical study titled "Treatment of Complicated Parapneumonic Effusion With Fibrinolytic Therapy Versus VATs Decortication". This study aims to standardize the treatment of pleural space (parapneumonic) infections by comparing the difference in outcomes between 2 methods of treatment: early VATS (Video Assisted Thorascopic Surgery) decortication versus fibrinolytic therapy. During treatment, the patient's coagulopathy sta...
What is the current status of trial NCT03583931?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-07-26. Estimated completion is 2020-02-02.
What interventions are being tested in trial NCT03583931?
The interventions under investigation include: VATS Decortication (PROCEDURE), Fibrinolytic Therapy (DRUG).
Who is sponsoring clinical trial NCT03583931?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.